Unspecified investigational influenza drug

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified investigational influenza drug, covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects [Phase 2]